Investments (#)
Investments (USD)
Transactions
Recent transactions in the sector
| Company | Country | Funding round | Date | |
|---|---|---|---|---|
|
Judo Bio Inc Developer of oligonucleotide medicines delivered to the kidney. |
United States | Series A USD 100,000,000 (USD 100,000,000) |
7 Oct 2024 |
|
Genomics Medicine Ireland Ltd Dublin-based life sciences startup. |
Ireland | Series A USD 40,000,000 (USD 40,000,000) |
26 Oct 2016 |
|
Blend Therapeutics Inc Biotechnology company pioneering controlled combination medicines that overcome the limitations of conventional combination therapy. |
United States | Series B USD 21,000,000 (USD 21,000,000) |
7 Jan 2015 |
|
|
Blend Therapeutics Inc Biotechnology company pioneering controlled combination medicines that overcome the limitations of conventional combination therapy. |
United States | Series A |
6 Jan 2012 |
|
Limula SA |
Switzerland | N/A |
|
|
|
Limula SA |
Switzerland | N/A |
|
|
|
Limula SA |
Switzerland | N/A |
|
|
|
Limula SA |
Switzerland | N/A |
|
|
Prokarium Ltd Oral vaccine delivery platform. |
N/A |
||
|
|
Limula SA |
Switzerland | N/A |
|
|
|
Limula SA |
Switzerland | N/A |
Companies
Best funded companies in the sector
Biotechnology company pioneering controlled combination medicines that overcome the limitations of conventional combination therapy.
Business Classification
Parent business classification group
Pharmaceuticals & Medical Research